CLINICAL STUDIES
Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children1
Basil (Vasilios) D. Thanopoulos, MDa,
George S. Tsaousis, MDa,
Georgia N. Konstadopoulou, MDa and
Armine G. Zarayelyan, MDa
a Department of Pediatric Cardiology, "Aghia Sophia" Childrens Hospital, Athens, Greece
Manuscript received June 10, 1998;
revised manuscript received November 20, 1998,
accepted December 24, 1998.
Reprint requests and correspondence: Dr. Basil (Vasilios) D. Thanopoulos, Department of Pediatric Cardiology, "Aghia Sophia" Childrens Hospital, Thivon & Levadias Street, Athens 11527, Greece
OBJECTIVES
The aim of this study was to close muscular ventricular septal defects (MVSDs) in children, with a new device, the Amplatzer ventricular septal defect occluder (AVSDO).
BACKGROUND
The design of previously used devices for transcatheter closure of MVSDs is not ideal for this purpose and their use has been limited by several drawbacks.
METHODS
Six patients, aged 3 to 10 years, with MVSDs underwent transcatheter closure using the AVSDO. The device is a modified self-centering and repositionable Amplatzer device that consists of two low profile disks made of Nitinol wire mesh with a 7-mm connecting waist. The prosthesis size (connecting waist diameter) was chosen according to the measured balloon stretched VSD diameters. A 6-F or 7-F sheath was used for the delivery of the AVSDO. Fluoroscopy and transesophageal echocardiography were utilized for optimal guidance.
RESULTS
The location of the defect was midmuscular in five patients and beneath the pulmonary valve in one. The balloon stretched MVSD diameter ranged from 6 to 11 mm. Device placement was successful in all patients, and complete occlusion occurred in all six patients (95% confidence interval 54.06% to 100%). Two patients developed transient complete left bundle branch block. No other complications were observed.
CONCLUSIONS
This encouraging initial clinical success indicates that the AVSDO is a promising device for transcatheter closure of MVSDs in children. Further clinical trials and longer follow-up are needed before the widespread use of this technique can be recommended.
|
Abbreviations and Acronyms
| | ASD | = atrial septal defect | | MVSDs | = muscular ventricular septal defects | | Qp/Qs | = pulmonary/systemic flow ratio | | SPAP | = systolic pulmonary artery pressure | | TEE | = transesophageal echocardiography | | TGA | = transposition of the great arteries |
|
This article has been cited by other articles:

|
 |

|
 |
 
A Wahl and B Meier
Patent foramen ovale and ventricular septal defect closure
Heart,
January 1, 2009;
95(1):
70 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. M. Hijazi and S. M. Awad
Pediatric Cardiac Interventions
J. Am. Coll. Cardiol. Intv.,
December 1, 2008;
1(6):
603 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Szkutnik, S A Qureshi, J Kusa, E Rosenthal, and J Bialkowski
Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects
Heart,
March 1, 2007;
93(3):
355 - 358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Butera, M. Carminati, M. Chessa, L. Piazza, R. Abella, D. G. Negura, A. Giamberti, B. Claudio, A. Micheletti, Y. Tammam, et al.
Percutaneous closure of ventricular septal defects in children aged <12: early and mid-term results
Eur. Heart J.,
December 1, 2006;
27(23):
2889 - 2895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rabenstein, C. Boosfeld, R. Henrich, and C. Ell
First use of ventricular septal defect occlusion device for endoscopic closure of an esophagorespiratory fistula using bronchoscopy and esophagoscopy.
Chest,
September 1, 2006;
130(3):
906 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B D Thanopoulos and M L Rigby
Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder
Heart,
April 1, 2005;
91(4):
513 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Piechaud
Closing down: transcatheter closure of intracardiac defects and vessel embolisations
Heart,
December 1, 2004;
90(12):
1505 - 1510.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Holzer, D. Balzer, Q.-L. Cao, K. Lock, Z. M. Hijazi, and Amplatzer Muscular Ventricular Septal Defect Inves
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S. registry
J. Am. Coll. Cardiol.,
April 7, 2004;
43(7):
1257 - 1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B D Thanopoulos, G S Tsaousis, E Karanasios, N G Eleftherakis, and C Paphitis
Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children
Heart,
August 1, 2003;
89(8):
918 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B D Thanopoulos, G S Tsaousis, M Djukic, F Al Hakim, N G Eleftherakis, and S D Simeunovic
Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder
Heart,
March 1, 2002;
87(3):
260 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M L Rigby
Transoesophageal echocardiography during interventional cardiac catheterisation in congenital heart disease
Heart,
December 1, 2001;
86(90002):
ii23 - 29.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Okubo, L. N. Benson, D. Nykanen, A. Azakie, G. Van Arsdell, J. Coles, and W. G. Williams
Outcomes of intraoperative device closure of muscular ventricular septal defects
Ann. Thorac. Surg.,
August 1, 2001;
72(2):
416 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Pigula, P. Buenaventura, J. A. Ettedgui, and R. D. Siewers
Management of retroperitoneal arterial injury after heart catheterization in children
Ann. Thorac. Surg.,
May 1, 2000;
69(5):
1582 - 1584.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|